MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

03 Jun 2024

Thermo Fisher Scientific Inc the world leader in serving science, today unveiled the Thermo...

LIB Therapeutics Announces Positive Lerodalcibep Results from Two Phase 3 LIBerate Studies

The American Kidney Fund's Rare Kidney Disease Advocacy Day on Capitol Hill aims to gather support for legislation to boost awareness and treatment of rare kidney diseases.

Aileron Therapeutics will present Phase 1b trial data on low-dose LTI-03 for IPF at the 22nd International Colloquium on Lung and Airway Fibrosis

Enhancing Preclinical Research Support, SoBran, Inc. Expands BioScience Services to Los Angeles

Nnamdi Njoku Named President of Omnicell

By Omnicell, Inc.
Omnicell, Inc.
01 Jul 2026

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

By Novo Nordisk
Novo Nordisk
01 Jul 2026

Queue Secures $12.6 Million to Launch the World's First Fully Autonomous Robotic Pharmacy

By Queue
Queue
30 Jun 2026

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

By Avenacy
Avenacy
29 Jun 2026

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

By Johnson & Johnson
Johnson & Johnson
25 Jun 2026

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

By StatLab Medical Products
StatLab Medical Products
25 Jun 2026

The Digital Pharma Advances Conference 2026

Most Popular

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

By AstraZeneca

May 15
Biologic Therapy Improves Pregnancy Outcomes in High-Risk Antiphospholipid Syndrome Patients, Says HSS

By Hospital for Special Surgery

Apr 13
Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

By Nestlé Health Science U.S.

May 28

July 2026

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

LIB Therapeutics Announces Positive Lerodalcibep Results from Two Phase 3 LIBerate Studies

The American Kidney Fund's Rare Kidney Disease Advocacy Day on Capitol Hill aims to gather support for legislation to boost awareness and treatment of rare kidney diseases.

Aileron Therapeutics will present Phase 1b trial data on low-dose LTI-03 for IPF at the 22nd International Colloquium on Lung and Airway Fibrosis

Enhancing Preclinical Research Support, SoBran, Inc. Expands BioScience Services to Los Angeles

Nnamdi Njoku Named President of Omnicell

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

Queue Secures $12.6 Million to Launch the World's First Fully Autonomous Robotic Pharmacy

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

Most Popular

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

Biologic Therapy Improves Pregnancy Outcomes in High-Risk Antiphospholipid Syndrome Patients, Says HSS

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter